- ¥4bn
- ¥3bn
- ¥9bn
- 88
- 71
- 50
- 83
Annual balance sheet for Lihit Lab, fiscal year end - February 28th, JPY millions except per share, conversion factor applied.
2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | 2025 February 28th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | — | JAS | — | — | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 1,798 | 2,260 | 1,077 | 1,243 | 2,332 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1,885 | 1,651 | 1,766 | 1,729 | 1,829 |
| Total Inventory | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 6,156 | 6,550 | 6,025 | 5,746 | 7,206 |
| Net Property, Plant And Equipment | 5,529 | 5,360 | 5,208 | 5,810 | 4,659 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 12,867 | 13,330 | 12,732 | 13,118 | 13,432 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 1,338 | 1,311 | 785 | 1,081 | 1,302 |
| Long Term Debt | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 3,243 | 3,219 | 2,512 | 2,875 | 2,795 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 9,624 | 10,110 | 10,220 | 10,242 | 10,637 |
| Total Liabilities & Shareholders' Equity | 12,867 | 13,330 | 12,732 | 13,118 | 13,432 |
| Total Common Shares Outstanding |